Design, synthesis and cytotoxic properties of novel 1-[4-(2-alkylaminoethoxy)phenylcarbonyl]-3,5-bis(arylidene)-4-piperidones and related compounds

被引:71
作者
Das, Umashankar
Alcorn, Jane
Shrivastav, Anuraag
Sharma, Rajendra K.
De Clercq, Erik
Balzarini, Jan
Dimmock, Jonathan R.
机构
[1] Univ Saskatchewan, Coll Pharm & Nutr, Saskatoon, SK S7N 5C9, Canada
[2] Coll Med, Dept Pathol, Saskatoon, SK S7N 4H4, Canada
[3] Saskatoon Canc Ctr, Canc Res Unit, Saskatoon, SK S7N 4H4, Canada
[4] Katholieke Univ Leuven, Rega Inst Med Res, B-3000 Louvain, Belgium
关键词
N-acyl-4-piperidones; structure-cytotoxicity relationships; alpha; beta-unsaturated ketones; apoptosis;
D O I
10.1016/j.ejmech.2006.08.002
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The 3,5-bis(arylidene)-4-piperidones I contain the 1,5-diaryl-3-oxo-1,4-pentadienyl pharmacophore which is considered to interact at a complementary binding site in susceptible neoplasms. The hypothesis was formulated that the presence of an acyl group attached to the piperidyl nitrogen atom in series 1 may interact with an additional binding site thereby enhancing cytotoxic potencies. This concept led to the synthesis of various N-acyl-3,5-bis(arylidene)-4-pipetidones 3-7 many of which displayed significant cytotoxicity towards a variety of cancer cell lines. A comparison of the potencies between the compounds in series I and the related nonquaternary analogues 3-6 revealed that in approximately half of the comparisons made, the N-acyl analogues had increased potencies. (c) 2006 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:71 / 80
页数:10
相关论文
共 26 条
[1]  
Albert A., 1984, DETERMINATION IONIZA, P151
[2]  
Althaus B., 2000, TXB THERAPEUTICS DRU, P1724
[3]  
BALUJA G, 1964, CHEM IND-LONDON, P2053
[4]   5-SUBSTITUTED 2'-DEOXYURIDINES - CORRELATION BETWEEN INHIBITION OF TUMOR-CELL GROWTH AND INHIBITION OF THYMIDINE KINASE AND THYMIDYLATE SYNTHETASE [J].
BALZARINI, J ;
DECLERCQ, E ;
MERTES, MP ;
SHUGAR, D ;
TORRENCE, PF .
BIOCHEMICAL PHARMACOLOGY, 1982, 31 (22) :3673-3682
[5]   DEGRADATION AND INACTIVATION OF ANTITUMOR DRUGS [J].
BENVENUTO, JA ;
CONNOR, TH ;
MONTEITH, DK ;
LAIDLAW, JL ;
ADAMS, SC ;
MATNEY, TS ;
THEISS, JC .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1993, 82 (10) :988-991
[6]   SOME PRACTICAL CONSIDERATIONS AND APPLICATIONS OF THE NATIONAL-CANCER-INSTITUTE IN-VITRO ANTICANCER DRUG DISCOVERY SCREEN [J].
BOYD, MR ;
PAULI, KD .
DRUG DEVELOPMENT RESEARCH, 1995, 34 (02) :91-109
[7]   Quaternary ammonium analogs of ether lipids inhibit the activation of protein kinase C and the growth of human leukemia cell lines [J].
Civoli, F ;
Daniel, LW .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1998, 42 (04) :319-326
[8]  
*COL U DEP CHEM, 2000, MACROMODEL 7 1
[10]  
Delgardo J. N., 1998, WILSON GISVOLDS TXB, P367